FB
Fairfield Bio, Inc.
SEC filingOther · Bronx, NY
Amount raised$450Ksold at filing
Total offering$2M$1.6M still open
Investors in the raise1count reported to the SEC
FiledFeb 12, 2026first sale Jan 26, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Kevin SlavinExecutive Officer, Director
Mitchell WolfeExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.